US Patent Issued to Zhejiang Juvensis Therapeutics, Nanjing Juvensis Therapuetics on Sept. 22 for "Inactive telomerase, adenovirus associated virus and artificial mRNA having same and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,161, issued on Sept. 22, was assigned to Zhejiang Juvensis Therapeutics Co. Ltd. (Taizhou, China) and Nanjing Juvensis Therapuetics Co. Ltd. (Nanjing, China).

"Inactive telomerase, adenovirus associated virus and artificial mRNA having same and use thereof" was invented by Jiahao Zhang (Nanjing, China) and Xue Zeng (Taizhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses an inactive telomerase, which is a double mutant telomerase having double mutation sites Y707F and D868A. The present invention also discloses an adenovirus-inactive telomerase and an artificial mRNA-inactive telomerase having double mutation s...